Literature DB >> 12138163

The recombinant human TRPV6 channel functions as Ca2+ sensor in human embryonic kidney and rat basophilic leukemia cells.

Matthias Bödding1, Ulrich Wissenbach, Veit Flockerzi.   

Abstract

The activation mechanism of the recently cloned human transient receptor potential vanilloid type 6 (TRPV6) channel, originally termed Ca(2+) transporter-like protein and Ca(2+) transporter type 1, was investigated in whole-cell patch-clamp experiments using transiently transfected human embryonic kidney and rat basophilic leukemia cells. The TRPV6-mediated currents are highly Ca(2+)-selective, show a strong inward rectification, and reverse at positive potentials, which is similar to store-operated Ca(2+) entry in electrically nonexcitable cells. The gating of TRPV6 channels is strongly dependent on the cytosolic free Ca(2+) concentration; lowering the intracellular free Ca(2+) concentration results in Ca(2+) influx, and current amplitude correlates with the intracellular EGTA or BAPTA concentration. This is also the case for TRPV6-mediated currents in the absence of extracellular divalent cations; compared with endogenous currents in nontransfected rat basophilic leukemia cells, these TRPV6-mediated monovalent currents reveal differences in reversal potential, inward rectification, and slope at very negative potentials. Release of stored Ca(2+) by inositol 1,4,5-trisphosphate and/or the sarco/endoplasmic reticulum Ca(2+)-ATPase inhibitor thapsigargin appears not to be involved in TRPV6 channel gating in both cell lines but, in rat basophilic leukemia cells, readily activates the endogenous Ca(2+) release-activated Ca(2+) current. In conclusion, TRPV6, expressed in human embryonic kidney cells and in rat basophilic leukemia cells, functions as a Ca(2+)-sensing Ca(2+) channel independently of procedures known to deplete Ca(2+) stores.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12138163     DOI: 10.1074/jbc.M202822200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Homo- and heterotetrameric architecture of the epithelial Ca2+ channels TRPV5 and TRPV6.

Authors:  J G J Hoenderop; T Voets; S Hoefs; F Weidema; J Prenen; B Nilius; R J M Bindels
Journal:  EMBO J       Date:  2003-02-17       Impact factor: 11.598

Review 2.  Role of TRP ion channels in cancer and tumorigenesis.

Authors:  George Shapovalov; Abigael Ritaine; Roman Skryma; Natalia Prevarskaya
Journal:  Semin Immunopathol       Date:  2016-02-03       Impact factor: 9.623

Review 3.  Transient Receptor Potential (TRP) channels in T cells.

Authors:  Samuel Bertin; Eyal Raz
Journal:  Semin Immunopathol       Date:  2015-10-14       Impact factor: 9.623

4.  Ion channels as targets for cancer therapy.

Authors:  Minghua Li; Zhi-Gang Xiong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-06-27

Review 5.  Epithelial Ca2+ entry channels: transcellular Ca2+ transport and beyond.

Authors:  Ji-Bin Peng; Edward M Brown; Matthias A Hediger
Journal:  J Physiol       Date:  2003-07-17       Impact factor: 5.182

Review 6.  The role of the TRPV6 channel in cancer.

Authors:  V'yacheslav Lehen'kyi; Maylis Raphaël; Natalia Prevarskaya
Journal:  J Physiol       Date:  2012-02-13       Impact factor: 5.182

7.  CaT1 knock-down strategies fail to affect CRAC channels in mucosal-type mast cells.

Authors:  Heike Kahr; Rainer Schindl; Reinhard Fritsch; Barbara Heinze; Michael Hofbauer; Marlene E Hack; Manuel A Mörtelmaier; Klaus Groschner; Ji-Bin Peng; Hitomi Takanaga; Matthias A Hediger; Christoph Romanin
Journal:  J Physiol       Date:  2004-03-12       Impact factor: 5.182

8.  Hydrolysis of phosphatidylinositol 4,5-bisphosphate mediates calcium-induced inactivation of TRPV6 channels.

Authors:  Baskaran Thyagarajan; Viktor Lukacs; Tibor Rohacs
Journal:  J Biol Chem       Date:  2008-04-07       Impact factor: 5.157

9.  Weft, warp, and weave: the intricate tapestry of calcium channels regulating T lymphocyte function.

Authors:  Kyla D Omilusik; Lilian L Nohara; Shawna Stanwood; Wilfred A Jefferies
Journal:  Front Immunol       Date:  2013-06-24       Impact factor: 7.561

10.  In vivo detection of human TRPV6-rich tumors with anti-cancer peptides derived from soricidin.

Authors:  Chris V Bowen; Drew DeBay; H Stephen Ewart; Pamela Gallant; Sean Gormley; T Toney Ilenchuk; Umar Iqbal; Tyler Lutes; Marzia Martina; Geoffrey Mealing; Nadine Merkley; Sandra Sperker; Maria J Moreno; Christopher Rice; Raymond T Syvitski; John M Stewart
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.